Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-Dose vs High-Dose Interferon Alfa in Chronic Myelogenous Leukemia
NCT00002869Phase 3Unknown
- Sponsor
- Medical Research Council
- Start
- Apr 1995
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 3 trial of interferon alfa-n1 in chronic myelogenous leukemia (CML), sponsored by Medical Research Council. Status: unknown.
02
Drugs
interferon alfa-n1
03
Conditions
chronic myelogenous leukemia (CML)
Beyond the preview
Go deeper on NCT00002869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002869.